210 related articles for article (PubMed ID: 17452985)
1. Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function.
Markey MP; Bergseid J; Bosco EE; Stengel K; Xu H; Mayhew CN; Schwemberger SJ; Braden WA; Jiang Y; Babcock GF; Jegga AG; Aronow BJ; Reed MF; Wang JY; Knudsen ES
Oncogene; 2007 Sep; 26(43):6307-18. PubMed ID: 17452985
[TBL] [Abstract][Full Text] [Related]
2. Rb suppresses human cone-precursor-derived retinoblastoma tumours.
Xu XL; Singh HP; Wang L; Qi DL; Poulos BK; Abramson DH; Jhanwar SC; Cobrinik D
Nature; 2014 Oct; 514(7522):385-8. PubMed ID: 25252974
[TBL] [Abstract][Full Text] [Related]
3. Geminin is targeted for repression by the retinoblastoma tumor suppressor pathway through intragenic E2F sites.
Markey M; Siddiqui H; Knudsen ES
J Biol Chem; 2004 Jul; 279(28):29255-62. PubMed ID: 15084580
[TBL] [Abstract][Full Text] [Related]
4. Lamina-associated polypeptide 2alpha regulates cell cycle progression and differentiation via the retinoblastoma-E2F pathway.
Dorner D; Vlcek S; Foeger N; Gajewski A; Makolm C; Gotzmann J; Hutchison CJ; Foisner R
J Cell Biol; 2006 Apr; 173(1):83-93. PubMed ID: 16606692
[TBL] [Abstract][Full Text] [Related]
5. Control of glutamine metabolism by the tumor suppressor Rb.
Reynolds MR; Lane AN; Robertson B; Kemp S; Liu Y; Hill BG; Dean DC; Clem BF
Oncogene; 2014 Jan; 33(5):556-66. PubMed ID: 23353822
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the retinoblastoma-E2F pathway by the ubiquitin-proteasome system.
Sengupta S; Henry RW
Biochim Biophys Acta; 2015 Oct; 1849(10):1289-97. PubMed ID: 26319102
[TBL] [Abstract][Full Text] [Related]
7. RB family tumor suppressor activity may not relate to active silencing of E2F target genes.
Vormer TL; Wojciechowicz K; Dekker M; de Vries S; van der Wal A; Delzenne-Goette E; Naik SH; Song JY; Dannenberg JH; Hansen JB; Te Riele H
Cancer Res; 2014 Sep; 74(18):5266-76. PubMed ID: 25056122
[TBL] [Abstract][Full Text] [Related]
8. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.
Xie C; Lu H; Nomura A; Hanse EA; Forster CL; Parker JB; Linden MA; Karasch C; Hallstrom TC
Mol Cancer; 2015 Apr; 14():93. PubMed ID: 25907958
[TBL] [Abstract][Full Text] [Related]
9. Regulation of matrix metalloproteinase genes by E2F transcription factors: Rb-Raf-1 interaction as a novel target for metastatic disease.
Johnson JL; Pillai S; Pernazza D; Sebti SM; Lawrence NJ; Chellappan SP
Cancer Res; 2012 Jan; 72(2):516-26. PubMed ID: 22086850
[TBL] [Abstract][Full Text] [Related]
10. Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions.
Burkhart DL; Wirt SE; Zmoos AF; Kareta MS; Sage J
PLoS Genet; 2010 Jun; 6(6):e1001003. PubMed ID: 20585628
[TBL] [Abstract][Full Text] [Related]
11. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.
Helt AM; Galloway DA
J Virol; 2001 Aug; 75(15):6737-47. PubMed ID: 11435552
[TBL] [Abstract][Full Text] [Related]
12. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
Pappas L; Xu XL; Abramson DH; Jhanwar SC
Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
[TBL] [Abstract][Full Text] [Related]
13. Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.
Iwahori S; Hakki M; Chou S; Kalejta RF
J Biol Chem; 2015 Aug; 290(32):19666-80. PubMed ID: 26100623
[TBL] [Abstract][Full Text] [Related]
14. The RB/E2F pathway and regulation of RNA processing.
Ahlander J; Bosco G
Biochem Biophys Res Commun; 2009 Jul; 384(3):280-3. PubMed ID: 19401190
[TBL] [Abstract][Full Text] [Related]
15. Regulation of RB transcription in vivo by RB family members.
Burkhart DL; Ngai LK; Roake CM; Viatour P; Thangavel C; Ho VM; Knudsen ES; Sage J
Mol Cell Biol; 2010 Apr; 30(7):1729-45. PubMed ID: 20100864
[TBL] [Abstract][Full Text] [Related]
16. pRb-Independent growth arrest and transcriptional regulation of E2F target genes.
McCabe MT; Azih OJ; Day ML
Neoplasia; 2005 Feb; 7(2):141-51. PubMed ID: 15802019
[TBL] [Abstract][Full Text] [Related]
17. Activation of a retinoblastoma-protein-dependent pathway by sphingosine.
Dbaibo GS; Wolff RA; Obeid LM; Hannun YA
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):453-9. PubMed ID: 7654183
[TBL] [Abstract][Full Text] [Related]
18. Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein.
Arroyo M; Raychaudhuri P
Nucleic Acids Res; 1992 Nov; 20(22):5947-54. PubMed ID: 1461728
[TBL] [Abstract][Full Text] [Related]
19. Regulation of BRCA1 expression by the Rb-E2F pathway.
Wang A; Schneider-Broussard R; Kumar AP; MacLeod MC; Johnson DG
J Biol Chem; 2000 Feb; 275(6):4532-6. PubMed ID: 10660629
[TBL] [Abstract][Full Text] [Related]
20. Rb inhibits E2F-1-induced cell death in a LXCXE-dependent manner by active repression.
Pennaneach V; Barbier V; Regazzoni K; Fotedar R; Fotedar A
J Biol Chem; 2004 May; 279(22):23376-83. PubMed ID: 15016799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
